Literature DB >> 23913015

PharmGKB summary: methylene blue pathway.

Ellen M McDonagh1, José M Bautista, Ilan Youngster, Russ B Altman, Teri E Klein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23913015      PMCID： PMC4091817          DOI： 10.1097/FPC.0b013e32836498f4

Source DB:  PubMed          Journal:  Pharmacogenet Genomics        ISSN： 1744-6872            Impact factor:   2.089


× No keyword cloud information.
  112 in total

1.  Glucose-6-phosphate dehydrogenase deficiency and safety of methylene blue.

Authors:  Olaf Müller; Peter Meissner; Ulrich Mansmann
Journal:  Drug Saf       Date:  2012-01-01       Impact factor: 5.606

2.  Methylene blue reduces aβ levels and rescues early cognitive deficit by increasing proteasome activity.

Authors:  David X Medina; Antonella Caccamo; Salvatore Oddo
Journal:  Brain Pathol       Date:  2011-03       Impact factor: 6.508

3.  Methylene blue as the future protecting agent for ischemic brain injury?

Authors:  Abele Donati; Erica Adrario; Paolo Pelaia; Jean-Charles Preiser
Journal:  Crit Care Med       Date:  2010-11       Impact factor: 7.598

Review 4.  "Lest we forget you--methylene blue...".

Authors:  R Heiner Schirmer; Heike Adler; Marcus Pickhardt; Eckhard Mandelkow
Journal:  Neurobiol Aging       Date:  2011-02-12       Impact factor: 4.673

Review 5.  How Romanowsky stains work and why they remain valuable - including a proposed universal Romanowsky staining mechanism and a rational troubleshooting scheme.

Authors:  R W Horobin
Journal:  Biotech Histochem       Date:  2011-02       Impact factor: 1.718

Review 6.  Oxidative stress, inflammation and carcinogenesis are controlled through the pentose phosphate pathway by transaldolase.

Authors:  Andras Perl; Robert Hanczko; Tiffany Telarico; Zachary Oaks; Steve Landas
Journal:  Trends Mol Med       Date:  2011-03-02       Impact factor: 11.951

7.  Drugs: a tangled web of targets.

Authors:  Lauren Gravitz
Journal:  Nature       Date:  2011-07-13       Impact factor: 49.962

8.  Glucose-6-phosphate dehydrogenase (G6PD) mutations database: review of the "old" and update of the new mutations.

Authors:  Angelo Minucci; Kamran Moradkhani; Ming Jing Hwang; Cecilia Zuppi; Bruno Giardina; Ettore Capoluongo
Journal:  Blood Cells Mol Dis       Date:  2012-01-30       Impact factor: 3.039

9.  PharmGKB summary: very important pharmacogene information for G6PD.

Authors:  Ellen M McDonagh; Caroline F Thorn; José M Bautista; Ilan Youngster; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2012-03       Impact factor: 2.089

Review 10.  Methemoglobinemia: pathogenesis, diagnosis, and management.

Authors:  Anna Skold; Dominique L Cosco; Robin Klein
Journal:  South Med J       Date:  2011-11       Impact factor: 0.954
View more
  7 in total

Review 1.  8-Aminoquinoline Therapy for Latent Malaria.

Authors:  J Kevin Baird
Journal:  Clin Microbiol Rev       Date:  2019-07-31       Impact factor: 26.132

2.  Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for rasburicase therapy in the context of G6PD deficiency genotype.

Authors:  M V Relling; E M McDonagh; T Chang; K E Caudle; H L McLeod; C E Haidar; T Klein; L Luzzatto
Journal:  Clin Pharmacol Ther       Date:  2014-05-02       Impact factor: 6.875

3.  Systems biology analysis of longitudinal functional response of endothelial cells to shear stress.

Authors:  Nassim E Ajami; Shakti Gupta; Mano R Maurya; Phu Nguyen; Julie Yi-Shuan Li; John Y-J Shyy; Zhen Chen; Shu Chien; Shankar Subramaniam
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-26       Impact factor: 11.205

4.  Methylation of protein aspartates and deamidated asparagines as a function of blood bank storage and oxidative stress in human red blood cells.

Authors:  Julie A Reisz; Travis Nemkov; Monika Dzieciatkowska; Rachel Culp-Hill; Davide Stefanoni; Ryan C Hill; Tatsuro Yoshida; Andrew Dunham; Tamir Kanias; Larry J Dumont; Michael Busch; Elan Z Eisenmesser; James C Zimring; Kirk C Hansen; Angelo D'Alessandro
Journal:  Transfusion       Date:  2018-10-12       Impact factor: 3.157

5.  Methylene Blue in the Treatment of Neuropsychiatric Disorders.

Authors:  Martin Alda
Journal:  CNS Drugs       Date:  2019-08       Impact factor: 5.749

Review 6.  PharmGKB summary: uric acid-lowering drugs pathway, pharmacodynamics.

Authors:  Ellen M McDonagh; Caroline F Thorn; John T Callaghan; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2014-09       Impact factor: 2.089

7.  Chlorella vulgaris supplementation effects on performances, oxidative stress and antioxidant genes expression in liver and ovaries of New Zealand White rabbits.

Authors:  A B Sikiru; A Arangasamy; I C Alemede; P R Guvvala; S S A Egena; J R Ippala; R Bhatta
Journal:  Heliyon       Date:  2019-09-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.